Possible scenario
Open Dataset Accelerates
45% Chance
The most likely path is that the $1.8 billion program moves forward as a public-private consortium with staged releases, access controls, and strong participation from cloud and AI labs. The 2022-2026 trend favors larger biological foundation-model datasets, and the White House's recent open-model exemption reduces the chance of an immediate shutdown.
Secondary impacts
- Technology +1.2%
- Healthcare +0.9%
Tickers
- TEM+2.2%
- NVDA+1.9%
- MSFT+1.6%
- META+1.0%
- +0.6%
Portfolio impact
S&P 500+0.7%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.